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A Novel Leucine to Valine Mutation in Residue 7 of the Helix
Initiation Motif of Keratin10 Leads to Bullous Congenital
Ichthyosiform Erythroderma
To the Editor:
Bullous ichthyosiform erythroderma (BCIE, MIM #113800), also
known as epidermolytic hyperkeratosis (EH), is an autosomal
dominant genodermatosis despite the fact that half of the cases
occur sporadically as the result of a new mutation (Goldsmith,
1976). The patients show blistering and erythema at birth, which
diminishes with age, and a generalized epidermolytic hyperkeratosis
in adulthood (Brocq, 1902). In BCIE, several point mutations have
been described in highly conserved regions of the rod domain of
either K1 (Chipev et al, 1992) or K10 (Rothnagel et al, 1992),
resulting in deleterious effects for ®lament assembly. Among them,
Arg156 of the keratin 10, which corresponds to the residue 10 of
helix initiation motif (HIM), is the most recurrent target of
mutations in patients with BCIE (Rothnagel et al, 1993); however,
there have been no reports of BCIE patients with mutations at
residue 7 of the HIM in either K10 or K1. Here we report a case
with a typical phenotype of BCIE caused by a novel missense
mutation, which leads to a single amino acid exchange from leucine
to valine at residue 7 in the HIM of K10 1A domain.
The proband, a 3-y-old male, was born at full term as the ®rst
child of healthy unrelated parents who had no eruption indicative
of nevoid BCIE (Fig 1A). Within a day after the birth, erythema
with thick scale developed on the whole body and blisters and
erosions were noticed on the hips and the ¯exural surface of
extremities. Skin biopsy was performed and the diagnosis of BCIE
was made. Neither cutaneous nor extracutaneous abnormalities
were noted except for BCIE. Although the severity of skin lesions
gradually decreased, hyperkeratosis with pigmentation continued
and small blisters sometimes appeared on the extremities at the age
of three. Histologic examination revealed the typical features of
epidermolytic hyperkeratosis; vacuolization with large cytoplasmic
granules in the granular layer and marked hyperkeratosis in the
stratum corneum. Electron microscopy showed perinuclear clump-
ing of keratin ®laments, or deposits of clumps as large electron
dense materials in the cytoplasm of keratinocytes, compatible with
BCIE.
For mutational analysis, genomic DNA was extracted from the
peripheral blood and DNA encoding the 1A region of K10 was
ampli®ed using speci®c oligonucleotides, 5¢-GGAAGCTATG-
GAAGTAGCAGCT-3¢ and antisense, 5¢-GCATAGTGAACA-
GCCACATTGTGC-3¢. Direct sequencing of polymerase chain
reaction products including exon 1 of KRT 10 using an ABI 310
automated sequencer revealed that the proband had a C to G
transversion at nucleotide position 457 (457C®G), compared with
the normal sequence (Fig 1B). This transversion resulted in
substitution of a leucine (CTG) by valine (GTG) at codon 153
(L153V), which corresponded to the residue 7 of the HIM of
keratin 10. The sequences from both unaffected parents showed the
wild-type sequence at codon 153. The L153V mutation abolished a
recognition site of the restriction enzyme AlwN I (New England
BioLabs, Beverly, MA, Fig 1C). This mutation was not found in
50 normal unrelated Japanese individuals using the enzyme
digestion method and was not likely to be a polymorphism (data
not shown). No pathogenic mutations were detected within the
helix initiation and termination motifs of keratin 1 and 10, and
linker domain (L12) of keratin 10 in the patient's DNA.
The L153V in the HIM of the K10 polypeptide described in the
Japanese patient with typical BCIE was con®rmed to be a novel
mutation. This region of the keratin rod domain has been
implicated in intermediate ®lament assembly by cell culture (Letai
et al, 1992), murine transgenic studies (Vassar et al, 1991), and
chemical cross-linking analysis (Steinert et al, 1993). The ®rst 15
residues of the 1A segment (KVTMQNLNDRLASYL) are highly
conserved among type I keratins and thought to be involved in
®lament assembly through interactions with the 2B segment of
neighboring molecules (Steinert et al, 1993). Therefore any
mutations in this conserved region are likely to be deleterious
and lead to a disease phenotype. To date, 32 BCIE cases with a K10
mutation and 14 BCIE cases with a K1 mutation were reported.
Among the cases with a K10 mutation, 19 cases had the mutation of
Arg156 at the highly conserved residue 10 within the HIM, and this
site is thought to be mutation prone; however, there have been no
reports of mutations at Leu153 in BCIE that correspond to the
residue 7 of the HIM. The leucine at the residue 7 of HIM is highly
conserved throughout the human keratins and intermediate
®laments gene and from other species. Valine is a hydrophobic
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Figure 1. Identi®cation of a missense mutation L153V in KRT 10
in the BCIE patient. (A) There were no other affected members of the
family except the proband. (B) Direct sequencing analysis of the exon 1
of KRT10 in the proband revealed a heterozygous C-to-G transition
(arrow) at nucleotide position 457, compared with the normal sequence.
This substitution mutation caused an amino acid change from leucine to
valine at codon 153 (L153V), which corresponded to the residue 7 of
the helix initiation motif of keratin 10. (C) The presence of the
mutation was veri®ed by restriction enzyme digestion. The L153V
mutation abolished a recognition site of restriction enzyme AlwN I. In
the case of the normal allele, the 440 bp fragment was digested to
fragments of 265 and 175 bp, whereas the mutant allele was not
digested. M, marker; 1, proband; 2, father; 3, mother.
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amino acid possessing similar structure to leucine but shorter side-
chain. The mutation from leucine to valine is pathogenic despite
the fact that it is a substitution to a similar amino acid attesting the
conservation and functional importance of this protein motif. In
K14, a type 1 keratin expressed in the basal keratinocytes, there was
one report with a mutation at residue 7 of HIM (L122F), resulting
in a milder disease phenotype of epidermolysis bullosa simplex
(Yamanishi et al, 1994). Phenylalanine is a hydrophobic amino acid
similar to leucine but having a larger side chain. This case further
supports the idea that the mutation at HIM residue 7 of type I
keratin is pathogenic, even if the mutation is a substitution to a
similar, hydrophobic residue. More cases should be accumulated to
clarify the genotype-phenotype relationship of the mutation at this
residue.
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Compound Heterozygous TGM1 Mutations Including a Novel
Missense Mutation L204Q in a Mild Form of Lamellar
Ichthyosis
To the Editor:
Since the identi®cation of TGase 1 gene (TGM1) mutations in a
number of families with lamellar ichthyosis (LI) in 1995 (Huber et
al, 1995; Russell et al, 1995), additional TGM1 mutations have
been reported in LI families, despite the fact that LI may be
genetically heterogeneous (Parmentier et al, 1996; Fischer et al,
2000; Virolainen et al, 2000). Whereas genotype/phenotype
correlations in LI have been studied for several years, the exact
nature of the relationship has yet to be fully elucidated (Hennies et
al, 1998; Laiho et al, 1997, 1999; Shevchenko et al, 2000).
In this study, we have identi®ed the heterozygous TGM1
mutations, L204Q and R306W, in a patient with mild lamellar
ichthyosis who showed a unique but restricted distribution of
lamellar scales.
The patient, a Japanese female and the third child of
nonconsanguineous parents, was born by normal vaginal delivery
and was not a collodion baby. During the perinatal period, she was
generally healthy and the skin covering her entire body appeared
normal without ectropion or eclabium (Fig 1a). She had no other
congenital anomalies. During infancy, thick scales appeared, mainly
on the trunk, and the severity of the scaling was stable throughout
her life without use of systemic retinoids or topical steroid
treatment, although the scaling worsened and affected areas
enlarged in the summer.
The patient's elder sister died when she was 1 wk old. The cause
of the sister's death was not known in detail except that she suffered
from ichthyosis. There was no other family history of congenital
ichthyosis and the patient's three remaining children displayed no
symptoms related to ichthyosis.
Physical examination of the patient at 56 years of age revealed
dark gray, thick, lamellar scales covering the neck, abdomen, center
of the back, and bilateral axillae (Fig 1b±d). The skin on her face
and extremities appeared normal and hyperkeratosis was not seen
on either her palms or her soles. Her hair, teeth, and nails also
appeared normal. Extracutaneous symptoms were not found.
Steroid sulfatase activity in the peripheral blood sample was normal.
Light microscopy of the lesional skin sample from the patient
showed marked hyperkeratosis with only a small number of
parakeratotic cells. Electron microscopic examination revealed the
disturbance of thickening of the corni®ed cell envelope during the
keratinization of the patient's epidermis.
Immuno¯uorescent labeling was performed using goat poly-
clonal anti-TGase 1 antibody (Kim et al, 1992, 1995) and rabbit
polyclonal anti-TGase 3 antibody (Tarcsa et al, 1997) (generous
gifts from Dr. Soo-Youl Kim) as described previously (Akiyama et al,
1999). Immuno¯uorescence demonstrated a reduced expression of
the TGase 1 molecule in the granular layer of patient's epidermis
(Fig 2a), although TGase 3 expression was normal (Fig 2b).
In situ TGase activity assay was performed using monodansylca-
daverine as a substrate in the patient's skin as described previously
(Aeschlimann et al, 1993; Hohl et al, 1998; Akiyama et al, 2000). At
pH 8.4 buffer conditions for the detection of both TGases 1 and 3
activity, cytoplasmic and weak membranous labeling was observed
in the granular layer cells both within the patient's epidermis and in
the control normal human epidermis (Fig 2c, d). At pH 7.4 buffer
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